{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:04:59Z","timestamp":1794866699738,"version":"4.9.1"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The South-Eastern Norway Regional Health Authority","award":["2015051"],"award-info":[{"award-number":["2015051"]}]},{"name":"The South-Eastern Norway Regional Health Authority","award":["2018061"],"award-info":[{"award-number":["2018061"]}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF148"],"award-info":[{"award-number":["DNRF148"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["190345"],"award-info":[{"award-number":["190345"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2018\/703"],"award-info":[{"award-number":["2018\/703"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2018\/735"],"award-info":[{"award-number":["2018\/735"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Stockholm","award":["FoUI-961412"],"award-info":[{"award-number":["FoUI-961412"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02614"],"award-info":[{"award-number":["2018-02614"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2025,6,4]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The advent of biological drugs has revolutionised management of inflammatory bowel disease (IBD). However, the extent to which these novel pharmacological drugs have reduced the need for surgical treatment remains incompletely quantified.<\/jats:p>\n                    <jats:p>We aimed to investigate the risk of first, major surgery in IBD in a population-based, large epidemiological study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We empanelled a cohort comprising all 85\u2009974 patients diagnosed with ulcerative colitis (UC) and 42\u2009760 with Crohn\u2019s disease (CD) in Norway and Sweden in 1987 through 2017. We used log-rank tests to compare the cumulative probability of surgical treatment for UC and CD. Using multivariable Cox proportional hazards models, we estimated hazard ratios (HR) with 95% CIs by year of diagnosis, age, sex and extent of disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a mean follow-up of 9.9 years, surgery was undertaken in 11\u2009187 (13.0%) patients with UC (12.3 per 1000 person-years) and in 11\u2009307 (26.4%) patients with CD (30.0 per 1000 person-years). In UC, the cumulative 5-year probability of surgery decreased from 16.2% in patients diagnosed in 1987\u20131994 to 5.8% in those diagnosed in 2011\u20132017 (p&lt;0.001). In CD, the corresponding decline was from 30.1% to 13.9% (p&lt;0.001). In multivariable analyses, the likelihood of surgical treatment decreased during the study period by 61% (HR 0.39, 95%\u2009CI 0.36 to 0.42) in UC and by 31% (HR 0.69, 95%\u2009CI 0.65 to 0.75) in CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Following the introduction of biologic drugs, the need for surgical treatments has been dramatically reduced in patients with UC and moderately reduced in patients with CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2025-001828","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:05:14Z","timestamp":1750392314000},"page":"e001828","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Temporal trends in surgical treatment of inflammatory bowel disease following introduction of biological drugs in Norway and Sweden"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-2903","authenticated-orcid":false,"given":"Amanda","family":"H\u00f6gd\u00e9n","sequence":"first","affiliation":[{"name":"Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Surgery, S\u00f6dersjukhuset, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0264-6378","authenticated-orcid":false,"given":"Vera","family":"Perrin","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-5791","authenticated-orcid":false,"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Kalager","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway"},{"name":"Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-7332","authenticated-orcid":false,"given":"Tine","family":"Jess","sequence":"additional","affiliation":[{"name":"Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg Universitet, Copenhagen, Denmark"},{"name":"Department of Gastroenterology and Hepatology, Aalborg Universitetshospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6859-4648","authenticated-orcid":false,"given":"Weimin","family":"Ye","sequence":"additional","affiliation":[{"name":"Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-192X","authenticated-orcid":false,"given":"Jessica","family":"Young","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Unit of Epidemiology, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-3978","authenticated-orcid":false,"given":"Lise M\u00f8rkved","family":"Helsingen","sequence":"additional","affiliation":[{"name":"University of Oslo Faculty of Medicine, Oslo, Norway"},{"name":"Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-5152","authenticated-orcid":false,"given":"Erle","family":"Refsum","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4938-6640","authenticated-orcid":false,"given":"Johannes","family":"Blom","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Surgery, S\u00f6dersjukhuset, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"2026010701052674000_12.1.e001828.1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3349\/ymj.2021.62.2.99","article-title":"Incidence and Prevalence of Inflammatory Bowel Disease across Asia","volume":"62","author":"Park","year":"2021","journal-title":"Yonsei Med J"},{"key":"2026010701052674000_12.1.e001828.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"2026010701052674000_12.1.e001828.3","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab029"},{"key":"2026010701052674000_12.1.e001828.4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MOG.0000000000000361","article-title":"Surgical rates in the era of biological therapy: up, down or unchanged?","volume":"33","author":"Olivera","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(15)00068-9","article-title":"Early combined immunosuppression for the management of Crohn\u2019s disease (REACT): a cluster randomised controlled trial","volume":"386","author":"Khanna","year":"2015","journal-title":"The Lancet"},{"key":"2026010701052674000_12.1.e001828.6","first-page":"413","article-title":"Is top-down therapy a more effective alternative to conventional step-up therapy for Crohn\u2019s disease?","volume":"31","author":"Tsui","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.7","doi-asserted-by":"publisher","DOI":"10.1093\/ECCO-JCC\/JJAB178"},{"key":"2026010701052674000_12.1.e001828.8","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz180"},{"key":"2026010701052674000_12.1.e001828.9","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00034-7"},{"key":"2026010701052674000_12.1.e001828.10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2468-1253(22)00001-2","article-title":"New insights on the surgical management of ulcerative colitis in the 21st century","volume":"7","author":"Kotze","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026010701052674000_12.1.e001828.11","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa173"},{"key":"2026010701052674000_12.1.e001828.12","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab112"},{"key":"2026010701052674000_12.1.e001828.13","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz187"},{"key":"2026010701052674000_12.1.e001828.14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab177"},{"key":"2026010701052674000_12.1.e001828.15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5009\/gnl210299","article-title":"Clinical Features and Long-term Prognosis of Crohn\u2019s Disease in Korea: Results from the Prospective CONNECT Study","volume":"16","author":"Hong","year":"2022","journal-title":"Gut Liver"},{"key":"2026010701052674000_12.1.e001828.16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3748\/wjg.v30.i9.1154","article-title":"Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018","volume":"30","author":"Kim","year":"2024","journal-title":"World J Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5009\/gnl210044","article-title":"Changes in the Long-term Prognosis of Crohn\u2019s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study","volume":"16","author":"Ye","year":"2022","journal-title":"Gut Liver"},{"key":"2026010701052674000_12.1.e001828.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-021-01781-x","article-title":"Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis","volume":"21","author":"Palacio","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.333"},{"key":"2026010701052674000_12.1.e001828.20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305607"},{"key":"2026010701052674000_12.1.e001828.21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.13835","article-title":"Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014","volume":"45","author":"Kirchgesner","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2026010701052674000_12.1.e001828.22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2016.524","article-title":"Improvements in the Long-Term Outcome of Crohn\u2019s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort","volume":"112","author":"Jeuring","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00365521.2016.1230777","article-title":"Clinical course of Crohn\u2019s disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009","volume":"52","author":"R\u00f6nnblom","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.24","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1093167"},{"key":"2026010701052674000_12.1.e001828.25","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv129"},{"key":"2026010701052674000_12.1.e001828.26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/00365521.2016.1200141","article-title":"Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009","volume":"51","author":"R\u00f6nnblom","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.10.039"},{"key":"2026010701052674000_12.1.e001828.28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/apt.16723","article-title":"Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases - a Danish nationwide cohort study","volume":"55","author":"Zhao","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026010701052674000_12.1.e001828.29","unstructured":"Anon . Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: a nationwide administrative database analysis - yoshida - 2024 - journal of gastroenterology and hepatology - wiley online library. Available: https:\/\/onlinelibrary-wiley-com.proxy.kib.ki.se\/doi\/10.1111\/jgh.16387 [Accessed 10 Jan 2025]."},{"key":"2026010701052674000_12.1.e001828.30","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otac041","article-title":"The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020","volume":"4","author":"Wewer","year":"2022","journal-title":"Crohns Colitis 360"},{"key":"2026010701052674000_12.1.e001828.31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315568"},{"key":"2026010701052674000_12.1.e001828.32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ecco-jcc\/jjx138","article-title":"Changes in Disease Behaviour and Location in Patients With Crohn\u2019s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort","volume":"12","author":"Lo","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026010701052674000_12.1.e001828.33","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/MIB.0000000000000787","article-title":"Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany","volume":"22","author":"Manetti","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2026010701052674000_12.1.e001828.34","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318440"},{"key":"2026010701052674000_12.1.e001828.35","doi-asserted-by":"crossref","unstructured":"Anon . P35 treatment outcomes of inflammatory bowel disease in the biological era\u2014a nationwide retrospective cohort study in three nordic countries: results from the trinordic study | journal of crohn\u2019s and colitis. Oxford Academic. Available: https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/Supplement_1\/S036\/5705315 [Accessed 18 Dec 2024].","DOI":"10.1093\/ecco-jcc\/jjz203.034"},{"key":"2026010701052674000_12.1.e001828.36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ueg2.12204","article-title":"Risk of hepato\u2010pancreato\u2010biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population\u2010based cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"UEG Journal"},{"key":"2026010701052674000_12.1.e001828.37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.annonc.2022.02.226","article-title":"Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel","volume":"33","author":"Yu","year":"2022","journal-title":"Ann Oncol"},{"key":"2026010701052674000_12.1.e001828.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-001037","article-title":"Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study","volume":"10","author":"Yu","year":"2023","journal-title":"BMJ Open Gastroenterol"},{"key":"2026010701052674000_12.1.e001828.39","unstructured":"Anon . National patient register. Socialstyrelsen; 2024. Available: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-patient-register\/ [Accessed 03 Jan 2025]."},{"key":"2026010701052674000_12.1.e001828.40","unstructured":"Anon . NOMESCO classification of surgical procedures. Available: https:\/\/norden.diva-portal.org\/smash\/get\/diva2:970547\/FULLTEXT01.pdf [Accessed 16 Dec 2024]."},{"key":"2026010701052674000_12.1.e001828.41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1008976","article-title":"Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity","volume":"13","author":"Bouwman","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026010701052674000_12.1.e001828.42","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14030"},{"key":"2026010701052674000_12.1.e001828.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00424-6"},{"key":"2026010701052674000_12.1.e001828.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.017"},{"key":"2026010701052674000_12.1.e001828.45","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000232"},{"key":"2026010701052674000_12.1.e001828.46","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw069"},{"key":"2026010701052674000_12.1.e001828.47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026010701052674000_12.1.e001828.48","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2023.05.051","article-title":"Early Ileocecal Resection for Crohn\u2019s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study","volume":"165","author":"Agrawal","year":"2023","journal-title":"Gastroenterology"},{"key":"2026010701052674000_12.1.e001828.49","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311003"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2025-001828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:05:51Z","timestamp":1767776751000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2025-001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjgast-2025-001828"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2025-001828","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}